|
1 |
02 11 2026 |
Indian pharma eyes bigger New Zealand market through FTA-driven regulatory reforms |
Pharmabiz |
India |
|
2 |
02 11 2026 |
29th edition of Bengaluru Tech Summit 2026 to be held from Nov 17-19 at Bangalore International Exhibition Centre |
Pharmabiz |
India |
|
3 |
02 11 2026 |
Bulk drugs imports decline 22%, exports grow over 11% in H1FY26 |
Pharmabiz |
India |
|
4 |
02 11 2026 |
FDI equity inflow into pharma sector hits a low at $100 million in Q1 FY27 |
Pharmabiz |
India |
|
5 |
02 11 2026 |
India’s medicine sales grow in double digits for four straight quarters, led by Chronic care drugs |
Health World(Economic Times) |
India |
|
6 |
01 11 2026 |
Sun Pharma secures CDSCO approval for generic Semaglutide pill |
Medical Dialogues |
India |
|
7 |
01 11 2026 |
ERP transformation key to ensuring pharma manufacturing continuity: Experts |
Business Standard |
India |
|
8 |
01 11 2026 |
Bengal researcher bags PharmInnova honour Shah calls for stronger Pharma R&D Push |
Times of India |
India |
|
9 |
31 10 2026 |
Health Ministry bars import of drugs with less than one year of residual shelf life |
Medical Dialogues |
India |
|
10 |
31 10 2026 |
CDSCO orders Sun Pharma to stop production of Ophthalmic drug including Loptepred , Nepalact |
Medical Dialogues |
India |
|
11 |
31 10 2026 |
DDS enhances efficacy & safety of drug via controlling rate, timing & location of drug release: Komal Saini |
Pharmabiz |
India |
|
12 |
31 10 2026 |
Centre eases shelf life norms for imported drugs |
Health World(Economic Times) |
India |
|
13 |
31 10 2026 |
Indian regulators order Sun Pharma to halt eye-care drug production at Assam plant |
Dealroom |
India |
|
14 |
30 10 2026 |
Bulk drug imports decline 18.25 per cent in August |
Pharmabiz |
India |
|
15 |
30 10 2026 |
India's pharma exports grow 4.9% to $16.14 bn in H1FY27 on Europe gains |
Business Standard |
India |
|
16 |
30 10 2026 |
Centre tightens oversight of high-risk solvents, mandates excipient testing to strengthen cough syrup quality |
Health World(Economic Times) |
India |
|
17 |
30 10 2026 |
DCGI suspends FatX import registration till July 2027 over unauthorized Fat-dissolving claim |
Medical Dialogues |
India |
|
18 |
30 10 2026 |
NPPA list revised MRPs for 643 cancer drug entries, Palbopro MRP falls 93% Keytruda , Tagrisso rates unchanged |
Medical Dialogues |
India |
|
19 |
30 10 2026 |
Nucelion secures manufacturing contract for Pandorum’s PRIP backed ophthalmology projetcs |
Health World(Economic Times) |
India |
|
20 |
30 10 2026 |
Piramal Pharma cutting China exposure to manage supply-chain resilience, says Nandini Piramal |
Health World(Economic Times) |
India |
